Aromatase inhibitors act through pure oestrogen deprivation to achieve an endocrine response in oestrogen receptor (ER)-positive breast cancer. Both experimental and clinical data now confirm that ...
New molecular entities (NMEs) are produced at the same rate today as they were 50 years ago. The industry has averaged one NME per company every 6 years, and its most successful firms have averaged ...